Anticoagulants; Increased
15
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Serum Potassium Prediction Using Machine Learning and Single-lead ECG
Prediction of 30-Day Readmission Using Machine Learning
Prediction of Expected Length of Hospital Stay Using Machine Learning
Home Hospital for Suddenly Ill Adults
Prediction of Patient Deterioration Using Machine Learning
Rural Home Hospital: Proof of Concept
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage
Remote Physician Care for Home Hospital Patients
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy
Hospital-Level Care at Home for Acutely Ill Adults
Noninvasive Measurement of Blood Coagulation